The results showed that high RPP25 expression in GBM, LAML, LUAD, SKCM, and UVM was significantly associated with poor patient prognosis, suggesting that RPP25 may be a potential pan-cancer prognostic indicator molecule. Here, RPP25 is linked to glioblastoma.